These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30257380)

  • 1. Radiation exposure triggers the progression of triple negative breast cancer via stabilizing ZEB1.
    Lin Y; Bai X; Zhou W; He Y; Wu Y; Wang X
    Biomed Pharmacother; 2018 Nov; 107():1624-1630. PubMed ID: 30257380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
    Luo N; Zhang K; Li X; Hu Y
    J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deubiquitinase BRCC3 increases the stability of ZEB1 and promotes the proliferation and metastasis of triple-negative breast cancer cells.
    Huang Q; Zheng S; Gu H; Yang Z; Lu Y; Yu X; Guo G
    Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):564-575. PubMed ID: 38449391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer.
    Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 Targets
    Ma JH; Qi J; Lin SQ; Zhang CY; Liu FY; Xie WD; Li X
    Mol Cancer Res; 2019 Nov; 17(11):2184-2195. PubMed ID: 31427441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.
    Al-Marsoummi S; Vomhof-DeKrey E; Basson MD
    Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of ZEB1 suppressed the formation of vasculogenic mimicry and epithelial-mesenchymal transition in the human breast cancer cell line MDA-MB-231.
    Liang W; Song S; Xu Y; Li H; Liu H
    Mol Med Rep; 2018 May; 17(5):6711-6716. PubMed ID: 29512767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1.
    Damiano V; Brisotto G; Borgna S; di Gennaro A; Armellin M; Perin T; Guardascione M; Maestro R; Santarosa M
    Genes Chromosomes Cancer; 2017 Feb; 56(2):147-158. PubMed ID: 27717206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide binding of transcription factor ZEB1 in triple-negative breast cancer cells.
    Maturi V; Enroth S; Heldin CH; Moustakas A
    J Cell Physiol; 2018 Oct; 233(10):7113-7127. PubMed ID: 29744893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transcription mediated Snail stabilization is involved in radiation exposure induced invasion and migration of hepatocarcinoma cells.
    Dong L; Zhang X; Xiang W; Ni J; Zhou W; Li H
    Biomed Pharmacother; 2018 Jul; 103():767-772. PubMed ID: 29684855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway.
    Wang D; Keyoumu K; Yu R; Wen D; Jiang H; Liu X; Di X; Zhang S
    Mol Med; 2024 May; 30(1):61. PubMed ID: 38760717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
    Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
    Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc finger E-box binding homeobox-1 (Zeb1) drives anterograde lysosome trafficking and tumor cell invasion via upregulation of Na+/H+ Exchanger-1 (NHE1).
    Dykes SS; Gao C; Songock WK; Bigelow RL; Woude GV; Bodily JM; Cardelli JA
    Mol Carcinog; 2017 Feb; 56(2):722-734. PubMed ID: 27434882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZEB1 inhibition sensitizes cells to the ATR inhibitor VE-821 by abrogating epithelial-mesenchymal transition and enhancing DNA damage.
    Song N; Jing W; Li C; Bai M; Cheng Y; Li H; Hou K; Li Y; Wang K; Li Z; Liu Y; Qu X; Che X
    Cell Cycle; 2018; 17(5):595-604. PubMed ID: 29157079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA UCA1 sponges miR-204-5p to promote migration, invasion and epithelial-mesenchymal transition of glioma cells via upregulation of ZEB1.
    Liang C; Yang Y; Guan J; Lv T; Qu S; Fu Q; Zhao H
    Pathol Res Pract; 2018 Sep; 214(9):1474-1481. PubMed ID: 30107990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid promotes the epithelial-to-mesenchymal transition of breast cancer cells through stabilization of Snail and transcriptional upregulation of Zeb1.
    Zhang S; Tang Z; Qing B; Tang R; Duan Q; Ding S; Deng D
    Eur J Pharmacol; 2019 Dec; 865():172745. PubMed ID: 31639340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral bidirectional transitions between epithelial and mesenchymal cells in triple-negative breast cancer.
    Yamamoto M; Sakane K; Tominaga K; Gotoh N; Niwa T; Kikuchi Y; Tada K; Goshima N; Semba K; Inoue JI
    Cancer Sci; 2017 Jun; 108(6):1210-1222. PubMed ID: 28371195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on inhibition of Britannin on triple-negative breast carcinoma through degrading ZEB1 proteins.
    Lu H; Wu Z; Wang Y; Zhao D; Zhang B; Hong M
    Phytomedicine; 2022 Sep; 104():154291. PubMed ID: 35839735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer.
    Al-Khadairi G; Naik A; Thomas R; Al-Sulaiti B; Rizly S; Decock J
    J Transl Med; 2019 Jan; 17(1):9. PubMed ID: 30602372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.